Clinical Trials in China / NCT06614660
Active, not recruiting
Observational
Metabolism Imaging-genomics for Predicting the Surgical Outcomes of Colorectal Cancer
NCT06614660 · tracked via the Priya Life Science China tracker
Condition(s) studied
Colorectal CancerImagingMetabolomicsPrognosisGenomics
Investigational drug(s) / intervention(s)
Metabolism genomics and imaging genomics
Metabolism genomics and imaging genomics: Pre-operative imaging images of the patient were collected prior to surgery, and 2 ml of the patient\'s blood specimen was collected to collect metabolism genomics and imaging genomics.
Study summary
In this study, the investigators constructed an imaging-metabolism prediction model for colorectal cancer by analysing the imaging and metabolomics features of colorectal cancer, in order to further adjust and guide the treatment plan.
Eligibility
Inclusion criteria:
* met the diagnostic criteria for gastrointestinal tumours;
* age \>18 years;
* planned to undergo surgery for gastrointestinal tumours according to the guidelines;
* signed an informed consent form; and e) agreed to undergo a biopsy in order to collect tissue from the tumour lesion.
Exclusion criteria:
* contraindications to imaging;
* withdrawal from the study cohort midway;
* metastatic foci in the liver, lung or other distant organs confirmed by CT, MRI or ultrasound imaging;
* gastrointestinal tumours combined with haemorrhage, obstruction or perforation;
* women who were pregnant, breastfeeding or planning to become pregnant during the study period.
Primary outcome measure(s)
- Overall survival — From date of diagnosis until the date of death from any cause or or loss to follow-up, whichever came first, assessed up to 60 months.
Overall survival was defined as time from date of diagnosis until the date of death from any cause or or loss to follow-up.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| The First Affiliated Hospital of Chongqing Medical University | Chongqing | Chongqing Municipality |
More First Affiliated Hospital of Chongqing Medical University trials in China
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06614660 on ClinicalTrials.gov ↗ ← All trials in China